Complementary and Innovative Method in Genital HPV Testing for Cervical Cancer Prevention

HPV vaccine for genital warts and cervical cancer

Those rumors are true! In 2006, the Food and Drug Administration [2] (FDA) approved the first vaccine (Gardasil) that protects against certain strains of human papillomavirus (HPV). Over 100 strands of HPV have been identified, and at least 40 strands can affect the genitals. Two strains, HPV-6 and HPV-11, are responsible for approximately 90 percent of genital warts. Two other strains, HPV-16 ...

HPV vaccine for genital warts and cervical cancer

Those rumors are true! In 2006, the Food and Drug Administration [2] (FDA) approved the first vaccine (Gardasil) that protects against certain strains of human papillomavirus (HPV). Over 100 strands of HPV have been identified, and at least 40 strands can affect the genitals. Two strains, HPV-6 and HPV-11, are responsible for approximately 90 percent of genital warts. Two other strains, HPV-16 ...

HPV DNA Testing: Technical and Programmatic Issues for Cervical Cancer Prevention in Low-Resource Settings

Primary HPV Testing vs. Co-testing for Cervical Cancer Screening

. Where the Story Begins The incidence of cervical cancer in the US has declined dramatically over the last half century and continues to decline to this day. In 1975, the incidence of cervical cancer was 14.8 per 100,000 women; by the year 2013 that number was only 6.4 per 100,000. Similarly, the mortality due to cervical cancer during the same period was reduced from 5.6 to 2.3 women per 100,...

Priority Setting for Improvement of Cervical Cancer Prevention in Iran

Background Cervical cancer is the fourth most common cancer among women worldwide. Organized cervical screening and vaccination against human papilloma virus (HPV) have been successful interventions for prevention of invasive cervical cancer (ICC). Because of cultural and religious considerations, ICC has low incidence in Iran and many other Muslim countries. There is no organized cervical scre...